nan 190 has been researched along with 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Audinot, V; Bervoets, K; Brocco, M; Canton, H; Gobert, A; Le Marouille-Girardon, S; Millan, MJ; Peglion, JL | 1 |
Bervoets, K; Brocco, M; Canton, H; Gobert, A; Lejeune, F; Millan, MJ; Peglion, JL; Rivet, JM; Widdowson, P | 1 |
2 other study(ies) available for nan 190 and 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine
Article | Year |
---|---|
Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Male; Piperazines; Rats; Rats, Wistar; Serotonin Antagonists; Structure-Activity Relationship | 1995 |
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively.
Topics: Animals; Behavior, Animal; Blepharoptosis; Body Temperature; Brain Chemistry; Ligands; Male; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses | 1993 |